CSTF2 | Cleavage stimulation factor, 3′ pre-RNA, subunit 2 | Xq22.1 | Upregulated | Maas et al,3 Olsen et al6 |
SLC genes (SLC7A7, SLC25A4) | Solute carrier family | 7A7: 14q11.225A4: 4q35 | Upregulated | van der Pouw Kraan et al,5 Yamada and Ymamoto14 |
CSF3R | Colony stimulating factor 3 receptor | 1p35–p34.3 | Upregulated | Maas et al,3 Olsen et al6 |
Troponin genes (TNNI1,TNNI2, TNNT2, TNNT3) | Troponin 1, troponin 2,Troponin T2, troponin T3 | I1: 1q31.3I2: 11p15.5T2: 1q32–q42.3T3: 11p15.5 | Upregulated | van der Pouw Kraan et al,5 Olsen et al6 |
ASL | Argininosuccinate lyase | 7cen–q11.2 | Downregulated | Maas et al,3 Liu et al4 |
TP53 | Tumour protein p53 | 17p13.1 | Downregulated | Maas et al,3 Liu et al4 |
TXK | TXK tyrosine kinase | 4p12 | Downregulated | Maas et al,3 Liu et al4 |
LAMR1 | Ribosomal protein SA | 3p21.3 | Downregulated | Olsen et al,6 Lequerré et al9 |
BMP8 | Bone morphogenetic protein 8 | 1p35–p32 | Downregulated | Maas et al,3 Liu et al4 |
CYP3A4 | Cytochrome P450, family 3, subfamily A | 7q21.1 | Olsen et al:6 upregulated | Olsen et al,6 Lequerré et al9 |
| | | Lequerré et al:9 downregulated in infliximab responders versus non-responders | |
KNG1 | Kininogen 1 | 3q27 | Maas et al3 and Liu et al:4 downregulated. Lequerré et al:9 upregulated in infliximab responders versus non-responders | Maas et al,3 Liu et al,4 Lequerré et al9 |
S100 genes (S100A10, S100A12) | S100 calcium binding protein | 1q21 | Olsen et al:6 downregulatedBatliwalla et al:7 upregulated | Olsen et al,6 Batliwalla et al7 |
PPP2R3 | Protein phosphatase 2 (formerly 2A), regulatory subunit B”, α | 3q22.1 | Maas et al3 and Liu et al:4 downregulatedvan der Pouw Kraan et al:5 higher expressed in RA-II group compared with RA-I group | Maas et al,3 Liu et al4van der Pouw Kraan et al5 |
MMP-3 | Matrix metalloproteinase 3 | 11q22.3 | van der Pouw Kraan et al:5 higher expressed in RA-I group compared with RA-II group. Lindberg et al:10 upregulated in infliximab responders | van der Pouw Kraan et al,5 Lindberg et al10 |